Status:

COMPLETED

Mild Depression 2 Week Observational Study

Lead Sponsor:

Stanford University

Collaborating Sponsors:

GlaxoSmithKline

Long Island Jewish Medical Center

Conditions:

Depressive Disorder

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control group...

Detailed Description

This is a multicenter study consisting of a Screen and Retest phase conducted in two separate days separated by a two-week period. After providing written informed consent and meeting protocol-defined...

Eligibility Criteria

Inclusion

  • :
  • " Male or female 18 years of age or older. " Presence of a Depressive disorder that presents as a dysthymic or minor depressive disorder and whose score on the Beck Depression Inventory (BDI) range between 11 and 20. Patients with major depression will be excluded.
  • " Is currently on stable doses of medications i.e., no change in treatment in the previous 30 days.
  • " Achieves a satisfactory score on the WRAT3 (standard score is \> 69). " Is capable of completing the self-reporting questionnaires. " Is willing and able to provide written informed consent and comply with the study protocol\


Exclusion

  • " Presence of a clinically significant comorbidity of an unstable or progressive nature (e.g., psychosis, delirium) that could, in the opinion of the investigator, prevent completion of the questionnaires or warrant immediate medical intervention.
  • " Participation in an investigational trial within the past 30 days. " Inability to communicate well with site study personnel, e.g. inability to read or understand English, poor mental development or impaired brain function.
  • " Patients with a clinical picture that meets criterion of major depression.

Key Trial Info

Start Date :

December 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00285831

Start Date

December 1 2005

End Date

March 1 2009

Last Update

September 9 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University School of Medicine

Stanford, California, United States, 94305